<p>随着全球市场面临对人工智能估值和经济不确定性的担忧，亚洲市场也未能幸免于这些挑战，在投资者谨慎的氛围中经历了波动。在这种情况下，亚洲那些内部持股比例较高的成长型公司尤其引人注目，因为它们通常表明管理层与股东之间存在强烈的内部信心和利益一致性。</p>
<h3>亚洲内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25.2%</td>
<td>110.4%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>老铺黄金 (SEHK:6181)</td>
<td>34.8%</td>
<td>34.3%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>32.6%</td>
</tr>
<tr>
<td>富临精工 (SZSE:300432)</td>
<td>11.6%</td>
<td>55.2%</td>
</tr>
<tr>
<td>Bora Pharmaceuticals (TWSE:6472)</td>
<td>11.9%</td>
<td>20.3%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们关于内部持股比例高的快速成长亚洲公司的 637 只股票的完整列表。</p>
<p>我们将从我们的筛选结果中选取一些进行分析。</p>
<h2>北京新诺药业研究 (SHSE:688621)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 北京新诺药业研究有限公司是一家专注于中国药物研发的合同研究公司，市值为 74.9 亿人民币。</p>
<p><strong>运营：</strong> 北京新诺药业研究有限公司作为合同研究组织，专注于中国的药物研发。</p>
<p><strong>内部持股比例：</strong> 35.3%</p>
<p><strong>收入增长预测：</strong> 每年 21.7%。</p>
<p>北京新诺药业研究显示出强劲的增长潜力，预计收益将以每年 33.02% 的速度增长，超过中国市场的 27.6%。尽管利润率从 19.1% 下降至 13.1%，但收入预计将以每年 21.7% 的速度增长，超过市场平均水平。公司的股本回报率预计将达到 24.2% 的高位，而其市盈率为 56.3 倍，低于行业标准，表明该行业相对具有价值。</p>
<ul>
<li>解锁我们对北京新诺药业研究股票分析的全面见解，详见本增长报告。</li>
<li>根据我们最近的估值报告，北京新诺药业研究的交易价格似乎超出了其估计价值。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown"/></p>
<p>截至 2025 年 11 月的 SHSE:688621 持股结构</p>
<h2>POCO Holding (SZSE:300811)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> POCO Holding Co., Ltd. 专注于开发、生产和销售用于电子设备的合金软磁粉和组件，市值为 220 亿人民币。</p>
<p><strong>运营：</strong> POCO Holding Co., Ltd. 的收入来自于合金软磁粉、合金软磁芯和电子设备用户的芯片电感组件的开发、生产和销售。</p>
<p><strong>内部持股比例：</strong> 24%</p>
<p><strong>收入增长预测：</strong> 每年 24.8%。</p>
<p>POCO Holding 展示出强劲的增长前景，预计收益将以每年 29.7% 的速度增长，超过中国市场的 27.6%。预计收入将以每年 24.8% 的速度增长，超过市场平均水平 14.4%。尽管最近股价波动，但公司在 2025 年前九个月的收入为 13 亿人民币，较去年增加了 0.3 亿人民币，表明其财务表现稳步提升。</p>
<ul>
<li>通过阅读我们的分析师估计报告，深入了解 POCO Holding 的表现。</li>
<li>根据我们的估值报告，POCO Holding 的股价可能偏高。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown"/></p>
<p>截至 2025 年 11 月的 SZSE:300811 持股结构</p>
<h2>Silergy (TWSE:6415)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Silergy Corp. 设计、制造和销售集成电路产品及相关技术服务，业务覆盖中国及国际市场，市值为 791.2 亿新台币。</p>
<p><strong>运营：</strong> 该公司主要通过其半导体部门产生收入，金额为 185.3 亿新台币。</p>
<p><strong>内部持股比例：</strong> 14.2%</p>
<p><strong>收入增长预测：</strong> 每年 15.5%。</p>
<p>Silergy 的增长轨迹稳健，预计收益将以每年 33.71% 的速度增长，超过台湾市场 20.2% 的预测。尽管第三季度销售和净收入较去年略有下降，但九个月的数据显示净收入从 13.91 亿新台币增加至 16.69 亿新台币。Silergy 的交易价格显著低于其估计公允价值，并且近期缺乏内部交易活动，仍然是亚洲增长领域一个引人注目的投资机会。</p>
<ul>
<li>点击探索我们在 Silergy 收益增长报告中的详细发现。</li>
<li>我们的估值报告显示 Silergy 可能被低估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown"/></p>
<p>截至 2025 年 11 月的 TWSE:6415 持股结构</p>
<h2>总结</h2>
<ul>
<li>在这里调查我们完整的 637 家快速成长的亚洲公司名单，这些公司内部持股比例高。</li>
<li>对其他可能性感兴趣？特朗普的石油繁荣已经到来——管道准备获利。发现 22 只美国股票正在乘风破浪。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论仅基于历史数据和分析师预测，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接拥有的股票。所有引用的预测收入和盈利增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>

Universal技术学院

富临精工

老铺黄金

<p>这篇文章强调了亚洲一些内部持股比例高的成长型公司，表明内部信心强烈。主要公司包括 UTI、Streamax Technology、Seers Technology、Novoray、Loadstar Capital、老铺黄金、J&V Energy Technology、Gold Circuit Electronics、富临精工和 Bora Pharmaceuticals。文章对北京阳诺药业研究、POCO Holding 和 Silergy 进行了详细分析，展示了它们的成长潜力和财务表现。文章强调了内部持股在管理层与股东利益对齐中的重要性</p>

<p>As global markets grapple with concerns over AI valuations and economic uncertainties, the Asian market has not been immune to these challenges, experiencing fluctuations amid investor caution. In this climate, growth companies in Asia with high insider ownership are particularly intriguing as they often indicate strong internal confidence and alignment of interests between management and shareholders.</p>
<div class="lb-trans"><p>随着全球市场面临对人工智能估值和经济不确定性的担忧，亚洲市场也未能幸免于这些挑战，在投资者谨慎的氛围中经历了波动。在这种情况下，亚洲那些内部持股比例较高的成长型公司尤其引人注目，因为它们通常表明管理层与股东之间存在强烈的内部信心和利益一致性。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Asia</h3>
<div class="lb-trans"><h3>亚洲内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25.2%</td>
<td>110.4%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>34.8%</td>
<td>34.3%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>32.6%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>11.6%</td>
<td>55.2%</td>
</tr>
<tr>
<td>Bora Pharmaceuticals (TWSE:6472)</td>
<td>11.9%</td>
<td>20.3%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25.2%</td>
<td>110.4%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>老铺黄金 (SEHK:6181)</td>
<td>34.8%</td>
<td>34.3%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>32.6%</td>
</tr>
<tr>
<td>富临精工 (SZSE:300432)</td>
<td>11.6%</td>
<td>55.2%</td>
</tr>
<tr>
<td>Bora Pharmaceuticals (TWSE:6472)</td>
<td>11.9%</td>
<td>20.3%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 637 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们关于内部持股比例高的快速成长亚洲公司的 637 只股票的完整列表。</p>
</div><p>We'll examine a selection from our screener results.</p>
<div class="lb-trans"><p>我们将从我们的筛选结果中选取一些进行分析。</p>
</div><h2>Beijing Sun-Novo Pharmaceutical Research (SHSE:688621)</h2>
<div class="lb-trans"><h2>北京新诺药业研究 (SHSE:688621)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is a contract research company focused on drug research and development in China, with a market cap of CN¥7.49 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 北京新诺药业研究有限公司是一家专注于中国药物研发的合同研究公司，市值为 74.9 亿人民币。</p>
</div><p><strong>Operations:</strong> Beijing Sun-Novo Pharmaceutical Research Co., Ltd. specializes in drug research and development as a contract research organization in China.</p>
<div class="lb-trans"><p><strong>运营：</strong> 北京新诺药业研究有限公司作为合同研究组织，专注于中国的药物研发。</p>
</div><p><strong>Insider Ownership:</strong> 35.3%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 35.3%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 21.7% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 每年 21.7%。</p>
</div><p>Beijing Sun-Novo Pharmaceutical Research shows strong growth potential, with earnings expected to increase by 33.02% annually, outpacing the Chinese market's 27.6%. Despite a decline in profit margins from 19.1% to 13.1%, revenue is forecasted to grow at a robust 21.7% per year, surpassing market averages. The company’s Return on Equity is projected to reach a high of 24.2%, while its P/E ratio of 56.3x remains below industry norms, suggesting relative value in the sector.</p>
<div class="lb-trans"><p>北京新诺药业研究显示出强劲的增长潜力，预计收益将以每年 33.02% 的速度增长，超过中国市场的 27.6%。尽管利润率从 19.1% 下降至 13.1%，但收入预计将以每年 21.7% 的速度增长，超过市场平均水平。公司的股本回报率预计将达到 24.2% 的高位，而其市盈率为 56.3 倍，低于行业标准，表明该行业相对具有价值。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Beijing Sun-Novo Pharmaceutical Research stock in this growth report.</li>
<li>In light of our recent valuation report, it seems possible that Beijing Sun-Novo Pharmaceutical Research is trading beyond its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对北京新诺药业研究股票分析的全面见解，详见本增长报告。</li>
<li>根据我们最近的估值报告，北京新诺药业研究的交易价格似乎超出了其估计价值。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown"/></p>
<p>SHSE:688621 Ownership Breakdown as at Nov 2025</p>
<div class="lb-trans"><p>截至 2025 年 11 月的 SHSE:688621 持股结构</p>
</div><h2>POCO Holding (SZSE:300811)</h2>
<div class="lb-trans"><h2>POCO Holding (SZSE:300811)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> POCO Holding Co., Ltd. specializes in developing, producing, and selling alloy soft magnetic powder and components for electronic equipment, with a market cap of CN¥22 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> POCO Holding Co., Ltd. 专注于开发、生产和销售用于电子设备的合金软磁粉和组件，市值为 220 亿人民币。</p>
</div><p><strong>Operations:</strong> POCO Holding Co., Ltd. generates revenue from the development, production, and sale of alloy soft magnetic powder, alloy soft magnetic cores, and chip inductance components for electronic equipment users.</p>
<div class="lb-trans"><p><strong>运营：</strong> POCO Holding Co., Ltd. 的收入来自于合金软磁粉、合金软磁芯和电子设备用户的芯片电感组件的开发、生产和销售。</p>
</div><p><strong>Insider Ownership:</strong> 24%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 24%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 24.8% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 每年 24.8%。</p>
</div><p>POCO Holding demonstrates strong growth prospects with earnings expected to grow at 29.7% annually, surpassing the Chinese market's 27.6%. Revenue is forecasted to increase by 24.8% per year, outpacing the market average of 14.4%. Despite a volatile share price recently, the company reported CNY 1.3 billion in revenue for the first nine months of 2025, up from CNY 1.23 billion last year, indicating steady progress in its financial performance.</p>
<div class="lb-trans"><p>POCO Holding 展示出强劲的增长前景，预计收益将以每年 29.7% 的速度增长，超过中国市场的 27.6%。预计收入将以每年 24.8% 的速度增长，超过市场平均水平 14.4%。尽管最近股价波动，但公司在 2025 年前九个月的收入为 13 亿人民币，较去年增加了 0.3 亿人民币，表明其财务表现稳步提升。</p>
</div><ul>
<li>Get an in-depth perspective on POCO Holding's performance by reading our analyst estimates report here.</li>
<li>According our valuation report, there's an indication that POCO Holding's share price might be on the expensive side.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过阅读我们的分析师估计报告，深入了解 POCO Holding 的表现。</li>
<li>根据我们的估值报告，POCO Holding 的股价可能偏高。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown"/></p>
<p>SZSE:300811 Ownership Breakdown as at Nov 2025</p>
<div class="lb-trans"><p>截至 2025 年 11 月的 SZSE:300811 持股结构</p>
</div><h2>Silergy (TWSE:6415)</h2>
<div class="lb-trans"><h2>Silergy (TWSE:6415)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Silergy Corp. designs, manufactures, and sells integrated circuit products and related technical services both in China and internationally, with a market cap of NT$79.12 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Silergy Corp. 设计、制造和销售集成电路产品及相关技术服务，业务覆盖中国及国际市场，市值为 791.2 亿新台币。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its semiconductors segment, amounting to NT$18.53 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过其半导体部门产生收入，金额为 185.3 亿新台币。</p>
</div><p><strong>Insider Ownership:</strong> 14.2%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 14.2%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 15.5% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 每年 15.5%。</p>
</div><p>Silergy's growth trajectory is robust, with earnings projected to rise 33.71% annually, outpacing the Taiwanese market's 20.2% forecast. Despite a slight dip in Q3 sales and net income compared to last year, nine-month figures show an increase in net income from TWD 1,391.25 million to TWD 1,668.88 million. Trading at a significant discount to its estimated fair value and lacking recent insider trading activity, Silergy remains an intriguing investment opportunity in Asia's growth sector.</p>
<div class="lb-trans"><p>Silergy 的增长轨迹稳健，预计收益将以每年 33.71% 的速度增长，超过台湾市场 20.2% 的预测。尽管第三季度销售和净收入较去年略有下降，但九个月的数据显示净收入从 13.91 亿新台币增加至 16.69 亿新台币。Silergy 的交易价格显著低于其估计公允价值，并且近期缺乏内部交易活动，仍然是亚洲增长领域一个引人注目的投资机会。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Silergy's earnings growth report.</li>
<li>Our valuation report here indicates Silergy may be undervalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击探索我们在 Silergy 收益增长报告中的详细发现。</li>
<li>我们的估值报告显示 Silergy 可能被低估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown"/></p>
<p>TWSE:6415 Ownership Breakdown as at Nov 2025</p>
<div class="lb-trans"><p>截至 2025 年 11 月的 TWSE:6415 持股结构</p>
</div><h2>Summing It All Up</h2>
<div class="lb-trans"><h2>总结</h2>
</div><ul>
<li>Investigate our full lineup of 637 Fast Growing Asian Companies With High Insider Ownership right here.</li>
<li>Interested In Other Possibilities? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里调查我们完整的 637 家快速成长的亚洲公司名单，这些公司内部持股比例高。</li>
<li>对其他可能性感兴趣？特朗普的石油繁荣已经到来——管道准备获利。发现 22 只美国股票正在乘风破浪。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论仅基于历史数据和分析师预测，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接拥有的股票。所有引用的预测收入和盈利增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div>

3 家内部持股比例高的亚洲成长型公司值得关注